Clinical trials
What are clinical trials?
Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in people. Often a clinical trial is used to learn if a new treatment is more effective and/or has less harmful side effects than the standard treatment.
On this page, we will present the ongoing and future clinical trials and studies, that are still seeking more participants.
- Vibrance Studies Seeking Participants for New Studies of Excessive Daytime Sleepiness. Alkermes plc
- FirstLight study a research study for individuals with Narcolepsy Type 1 (narcolepsy with cataplexy). Takeda Pharmaceuticals
- Mayo Clinic is seeking patients with idiopathic hypersomnia, ages 18-65
years to participate in a research study to evaluate the effect of low sodium oxybate. - IQVIA is currently looking for adults (≥18 years of age) who have been diagnosed with narcolepsy or IH currently taking Xywav® to take part in a paid research study.
- DUET Study: The DUET Study will evaluate daytime and nighttime effects of XYWAV® (low-sodium oxybate oral solution), also known as JZP258, in people with idiopathic hypersomnia (IH) or narcolepsy (Type 1 or Type 2).
Click here for the brochure. - Jazz Pharmaceuticals and IQVIA are currently looking for individuals (≥18 years of age) who have been diagnosed with NT1, NT2, or IH to take part in a paid research interview study. This research results will help us learn more about what it is like to live with NT1, NT2, or IH, including: impacts on daily life, a better understanding of NT1, NT2, or IH, and how to best measure symptoms and impacts of NT1, NT2, or IH.
Click here to enter. - Axsome Therapeutics. A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy.
Click here for the US.
Click here for Canada. - Mayo Clinic. A Study to Evaluate Safety, and Efficacy of SUVN-G3031 in Patients With Narcolepsy With and Without Cataplexy.
Click here for the US locations. - Boston Children’s Hospital. A study Validation of Pediatric Narcolepsy Patient Reported Outcomes.
Click here for more information. - ZEVRA Therapeutics. Study KP1077.D01 is a clinical trial evaluating the safety and efficacy of KP1077 capsules in adults with idiopathic hypersomnia (IH).
Find a study location here. - A web-based pediatric narcolepsy registry is an organized collection of data focused on health and quality of life information for children under the age of 18 and their caregivers.
Click CATNAP® Pediatric Narcolepsy Registry for more information.TM
